75. クッシング病
[臨床試験数:191,薬物数:172(DrugBank:48),標的遺伝子数:61,標的パスウェイ数:121

Searched query = "Cushing disease", "Cushing"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2016-002240-17-GB
(EUCTR)
16/05/201706/03/2017A Study of ATR-101 for the Treatment of Cushing’s SyndromeA Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ATR-101 for the Treatment of Cushing’s Syndrome endogenous Cushing’s syndrome
MedDRA version: 20.0;Level: SOC;Classification code 10014698;Term: Endocrine disorders;System Organ Class: 10014698 - Endocrine disorders ;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
Millendo Therapeutics, Inc.NULLNot Recruiting Female: yes
Male: yes
16Phase 2United States;United Kingdom
2NCT03053271
(ClinicalTrials.gov)
April 13, 20176/2/2017A Study of ATR-101 for the Treatment of Endogenous Cushing's SyndromeA Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ATR-101 for the Treatment of Cushing's SyndromeCushing SyndromeDrug: ATR-101;Drug: PlaceboMillendo Therapeutics US, Inc.NULLTerminated18 Years80 YearsAll4Phase 2United States;United Kingdom